DREAM anticorps (Met1, N-Term)
Aperçu rapide pour DREAM anticorps (Met1, N-Term) (ABIN2242434)
Antigène
Voir toutes DREAM (KCNIP3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Met1, N-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- CSEN, NT (M1) (Calsenilin, Kv Channel-interacting Protein 3, A-type Potassium Channel Modulatory Protein 3, DRE-antagonist Modulator, DREAM, KCNIP3, KChIP3)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human KChIP3 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
-
Autre désignation
- CSEN
-
UniProt
- Q9Y2W7
Antigène
-